William Bozeman – Trademark Portfolio

Entity Type: 01

William Bozeman has 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 5 Nice Classification classes, led by Class 41 (Education & Entertainment) and Class 44 (Medical Services). This trademark owner is based in Mesa, AZ.

4140 E Baseline Rd Ste 101

Mesa, AZ 85206

19 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

William Bozeman's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (9 filings)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (7 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

45
Legal & Security Services (2 filings)

Legal services; security services for the protection of property and individuals

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does William Bozeman have?

William Bozeman has 19 U.S. trademarks filed with the USPTO.

What trademark classes does William Bozeman file in?

William Bozeman files trademarks across 5 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 45 (Legal & Security Services), Class 5 (Pharmaceuticals). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What is William Bozeman's trademark registration success rate?

William Bozeman has a 0% trademark registration rate, with 0 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.